Erin McNamara

2.0k total citations · 1 hit paper
18 papers, 971 citations indexed

About

Erin McNamara is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Erin McNamara has authored 18 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Erin McNamara's work include Phagocytosis and Immune Regulation (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Erin McNamara is often cited by papers focused on Phagocytosis and Immune Regulation (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Erin McNamara collaborates with scholars based in United States, France and Canada. Erin McNamara's co-authors include Stephen E. Gould, Jeanne Cheung, Марина Москаленко, Peter Ebert, Jeong Kim, Marcia Belvin, Heather Maecker, Rebecca Hong, Yagai Yang and Ira Mellman and has published in prestigious journals such as Nature, Immunity and The Journal of Immunology.

In The Last Decade

Erin McNamara

18 papers receiving 951 citations

Hit Papers

MAP Kinase Inhibition Promotes T Cell and Anti-tumor Acti... 2016 2026 2019 2022 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin McNamara United States 8 624 366 336 135 94 18 971
Michiko Harao Japan 16 329 0.5× 377 1.0× 362 1.1× 101 0.7× 74 0.8× 36 915
Lucia Festino Italy 18 880 1.4× 375 1.0× 368 1.1× 76 0.6× 99 1.1× 39 1.2k
K. Papadopoulos United States 16 540 0.9× 299 0.8× 598 1.8× 103 0.8× 55 0.6× 56 1.1k
Rakesh Verma United States 10 549 0.9× 514 1.4× 522 1.6× 110 0.8× 67 0.7× 25 1.4k
Takehiro Nohara Japan 11 389 0.6× 192 0.5× 351 1.0× 90 0.7× 75 0.8× 25 784
Nicole Houston United States 18 635 1.0× 219 0.6× 375 1.1× 94 0.7× 35 0.4× 40 969
Crescenzo D’Alterio Italy 19 849 1.4× 533 1.5× 371 1.1× 70 0.5× 69 0.7× 36 1.3k
Maria Libera Ascierto United States 19 677 1.1× 577 1.6× 397 1.2× 82 0.6× 76 0.8× 44 1.2k
Li‐Chin Yao United States 11 497 0.8× 230 0.6× 287 0.9× 56 0.4× 168 1.8× 23 881

Countries citing papers authored by Erin McNamara

Since Specialization
Citations

This map shows the geographic impact of Erin McNamara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin McNamara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin McNamara more than expected).

Fields of papers citing papers by Erin McNamara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin McNamara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin McNamara. The network helps show where Erin McNamara may publish in the future.

Co-authorship network of co-authors of Erin McNamara

This figure shows the co-authorship network connecting the top 25 collaborators of Erin McNamara. A scholar is included among the top collaborators of Erin McNamara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin McNamara. Erin McNamara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Ran, Edward Dere, Mandy Kwong, et al.. (2024). A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTK. The AAPS Journal. 26(1). 11–11. 2 indexed citations
2.
Vollmar, Breanna S., Mingjian Fei, Wei‐Ching Liang, et al.. (2022). PEGylation of anti-MerTK Antibody Modulates Ocular Biodistribution. Bioconjugate Chemistry. 33(10). 1837–1851. 1 indexed citations
3.
Esen, Emel, Ismail Sergin, Rajiv Jesudason, et al.. (2020). MAP4K4 negatively regulates CD8 T cell–mediated antitumor and antiviral immunity. Science Immunology. 5(45). 22 indexed citations
4.
Cubas, Rafael, Марина Москаленко, Jeanne Cheung, et al.. (2018). Chemotherapy Combines Effectively with Anti–PD-L1 Treatment and Can Augment Antitumor Responses. The Journal of Immunology. 201(8). 2273–2286. 41 indexed citations
5.
Trout, Andrew T., Jeanne S. Chow, Erin McNamara, et al.. (2017). Association between Testicular Microlithiasis and Testicular Neoplasia: Large Multicenter Study in a Pediatric Population. Radiology. 285(2). 576–583. 23 indexed citations
6.
Ebert, Peter, Jeanne Cheung, Yagai Yang, et al.. (2016). MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade. Immunity. 44(3). 609–621. 527 indexed citations breakdown →
7.
Vitorino, Philip, Ailey Crow, Jesse Bakke, et al.. (2015). MAP4K4 regulates integrin-FERM binding to control endothelial cell motility. Nature. 519(7544). 425–430. 107 indexed citations
8.
Wilson, Catherine, Xiaofen Ye, Eva Lin, et al.. (2014). AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs. Cancer Research. 74(20). 5878–5890. 116 indexed citations
9.
McNamara, Erin, Ramiro J. Madden‐Fuentes, Jonathan C. Routh, et al.. (2014). Evaluation of cold ischemia for preservation of testicular function during partial orchiectomy in the rat model. Journal of Pediatric Urology. 10(4). 593–597. 3 indexed citations
10.
Wilson, Catherine, Thinh Q. Pham, Xiaofen Ye, et al.. (2014). Abstract 693: AXL tyrosine kinase inhibition selectively sensitizes mesenchymal cancer cells to antimitotic agents. Cancer Research. 74(19_Supplement). 693–693. 1 indexed citations
11.
Huseni, Mahrukh, Klára Tótpál, Changchun Du, et al.. (2014). Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models. Journal for ImmunoTherapy of Cancer. 2(S3). 1 indexed citations
12.
Boggs, Jason, Cornelis E. C. A. Hop, Erin McNamara, et al.. (2014). Assessment of the Hepatic CYP Reductase Null Mouse Model and Its Potential Application in Drug Discovery. Molecular Pharmaceutics. 11(3). 1062–1068. 2 indexed citations
13.
Huseni, Mahrukh, Klára Tótpál, Changchun Du, et al.. (2014). Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models. Journal for ImmunoTherapy of Cancer. 2(S3). 1 indexed citations
14.
Tate, Melissa L. Knothe, Jared O’Leary, Erin McNamara, Lan Cai, & Ulf Knothe. (2013). Lithotripsy stimulates new bone formation and mitigates loss of bone due to disuse in aged rats. Technology and Health Care. 21(6). 587–597. 6 indexed citations
15.
Wong, Harvey, Edna F. Choo, Bruno Alicke, et al.. (2012). Antitumor Activity of Targeted and Cytotoxic Agents in Murine Subcutaneous Tumor Models Correlates with Clinical Response. Clinical Cancer Research. 18(14). 3846–3855. 96 indexed citations
16.
Wong, Harvey, Edna F. Choo, Bruno Alicke, et al.. (2011). Abstract A11: Antitumor activity of targeted and cytotoxic agents in xenograft models correlates with clinical response: A pharmacokinetic-pharmacodynamic analysis.. Molecular Cancer Therapeutics. 10(11_Supplement). A11–A11. 3 indexed citations
17.
McNamara, Erin & Michael C. Archer. (2009). Ezetimibe reverses the inhibitory effects of dietary cholesterol on mammary tumorigenesis in rats. International Journal of Cancer. 127(4). 791–795. 3 indexed citations
18.
Murphy, Timothy F., et al.. (2001). Conservation of Outer Membrane Protein E among Strains of Moraxella catarrhalis. Infection and Immunity. 69(6). 3576–3580. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026